Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review
View abstract on PubMed
Summary
This summary is machine-generated.Tiopronin is a key treatment for cystinuria, but real-world safety data are limited. This study identified new safety concerns, especially in children, highlighting the need for better monitoring and education.
Area Of Science
- Pharmacovigilance
- Rare genetic disorders
- Pediatric pharmacology
Background
- Cystinuria is a rare genetic disorder causing recurrent kidney stones, primarily affecting children.
- Tiopronin is the main pharmacologic treatment for cystinuria when conservative measures fail.
- Real-world safety data for tiopronin are scarce, necessitating further investigation.
Purpose Of The Study
- To evaluate the adverse-event profile of tiopronin using real-world data.
- To identify known and novel safety signals associated with tiopronin use.
- To assess the safety of tiopronin, particularly in the pediatric population.
Main Methods
- Utilized the FDA Adverse Event Reporting System (FAERS) database from Q1 2014 to Q1 2025.
- Included deduplicated cases where tiopronin was the primary suspect drug.
- Employed MedDRA coding and multiple disproportionality algorithms for signal detection.
Main Results
- Identified 1,838 unique cases, with nearly 70% involving pediatric patients.
- Detected significant safety signals in seven System Organ Classes and 67 Preferred Terms.
- Observed unlabelled safety signals including hyposmia, skin atrophy, breath odor, and incorrect dosage, with the latter being critical in children.
Conclusions
- This pharmacovigilance study is the first FAERS-based analysis of tiopronin safety.
- Identified both known and novel safety signals, emphasizing challenges in pediatric dosing.
- Stressed the need for enhanced pharmacovigilance, accurate treatment oversight, and improved patient/clinician education.
Related Concept Videos
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...

